210 related articles for article (PubMed ID: 31625042)
1. At Odds About the Odds: Women's Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds.
Billington EO; Feasel AL; Kline GA
J Gen Intern Med; 2020 Jan; 35(1):276-282. PubMed ID: 31625042
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population.
Ratnasingam J; Niyaz M; Mariyappan S; Ong T; Chan SP; Hew FL; Yeap SS; Velaiutham S; Thambiah SC; Lekamwasam S
Arch Osteoporos; 2024 Mar; 19(1):18. PubMed ID: 38503995
[TBL] [Abstract][Full Text] [Related]
3. Comparison of treatment strategies and thresholds for optimizing fracture prevention in Canada: a simulation analysis.
Leslie WD; Morin SN; Lix LM; Binkley N
Arch Osteoporos; 2019 Dec; 15(1):4. PubMed ID: 31858278
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
Liu CS; Feasel AL; Kline GA; Billington EO
Osteoporos Int; 2021 Jul; 32(7):1421-1427. PubMed ID: 33462652
[TBL] [Abstract][Full Text] [Related]
5. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
[TBL] [Abstract][Full Text] [Related]
6. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
7. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
Dimai HP; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Fahrleitner-Pammer A; Pietschmann P; Muschitz C; McCloskey EV; Kanis JA
Arch Osteoporos; 2022 Nov; 17(1):141. PubMed ID: 36357621
[TBL] [Abstract][Full Text] [Related]
9. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
10. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
[TBL] [Abstract][Full Text] [Related]
11. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
[TBL] [Abstract][Full Text] [Related]
12. Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation.
Wilton-Clark MS; Feasel AL; Kline GA; Billington EO
Arch Osteoporos; 2020 Sep; 15(1):138. PubMed ID: 32888079
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective osteoporosis treatment thresholds in Greece.
Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
[TBL] [Abstract][Full Text] [Related]
14. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
[TBL] [Abstract][Full Text] [Related]
15. Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
Holloway KL; Mohebbi M; Betson AG; Hans D; Hyde NK; Brennan-Olsen SL; Kotowicz MA; Pasco JA
Osteoporos Int; 2018 Jan; 29(1):101-108. PubMed ID: 28940052
[TBL] [Abstract][Full Text] [Related]
16. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
[TBL] [Abstract][Full Text] [Related]
17. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent assessment thresholds to optimize patient care in a resource-limited setting: an analysis based on the Sri Lankan FRAX model.
Lekamwasam S; Abeygunasekara T; Rathnayake N; Liyanage G; Subasinghe S
Arch Osteoporos; 2022 May; 17(1):77. PubMed ID: 35553258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
